Microvascular perfusion heterogeneity contributes to peripheral vascular disease in metabolic syndrome

Journal of Physiology

Volumn 594, Issue 8, 2016, Pages 2233-2243

  Frisbee, Jefferson C ^a   Goodwill, Adam G ^a   Frisbee, Stephanie J ^a   Butcher, Joshua T ^a   Wu, Fan ^b   Chantler, Paul D ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOXANE A2; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; BLOOD FLOW; DISEASE SEVERITY; DYSLIPIDEMIA; GLYCEMIC CONTROL; HEMATOCRIT; HYPERTENSION; INCIDENCE; METABOLIC SYNDROME X; MICROVASCULARIZATION; MISSENSE MUTATION; MORBID OBESITY; MUSCLE FATIGUE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RAT; REVIEW; RISK FACTOR; SKELETAL MUSCLE; ANIMAL; COMPLICATION; HUMAN; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASES; VASCULARIZATION;

ANIMALS; HUMANS; METABOLIC SYNDROME X; MICROCIRCULATION; MUSCLE, SKELETAL; PERIPHERAL VASCULAR DISEASES; THROMBOXANES;

EID: 84919968866     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.285247     Document Type: Review

References (49)

1. Adachi T, Kikuchi N, Yasuda K, Anahara R, Gu N, Matsunaga T, Yamamura T, Mori C, Tsujimoto G, Tsuda K & Ishihara A (2007). Fibre type distribution and gene expression levels of both succinate dehydrogenase and peroxisome proliferator-activated receptor-γ coactivator-1α of fibres in the soleus muscle of Zucker diabetic fatty rats. Exp Physiol 92, 449-455.
2. Aleixandre de Artiñano A & Miguel Castro M (2009). Experimental rat models to study the metabolic syndrome. Br J Nutr 102, 1246-1253.
3. Barrett EJ & Liu Z (2013). The endothelial cell: an "early responder" in the development of insulin resistance. Rev Endocr Metab Disord 14, 21-27.
4. Bassingthwaighte JB, Liebovitch LS & West BJ (1994). Fractal Physiology. "Intraorgan Flow Heterogeneities", pp. 236-262. Oxford University Press.
5. Baumgartner WA Jr, Peterson AJ, Presson RG Jr, Tanabe N, Jaryszak EM & Wagner WW Jr (2004). Blood flow switching among pulmonary capillaries is decreased during high hematocrit. J Appl Physiol 97, 522-526.
6. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P & Showstack JA (1989). Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 12, 24-31.
7. Bohlen HG & Nase GP (2002). Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function. Am J Physiol Heart Circ Physiol 283, H391-H397.
8. Bouvet C, Belin de Chantemèle E, Guihot AL, Vessières E, Bocquet A, Dumont O, Jardel A, Loufrani L, Moreau P & Henrion D (2007). Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 50, 248-254.
9. Butcher JT, Goodwill AG, Stanley SC & Frisbee JC (2013). Blunted temporal activity of microvascular perfusion heterogeneity in metabolic syndrome: a new attractor for peripheral vascular disease? Am J Physiol Heart Circ Physiol 304, H547-H558.
10. Butcher JT, Stanley SC, Brooks SD, Chantler PD, Wu F, Frisbee JC (2014). Impact of increased intramuscular perfusion heterogeneity on skeletal muscle microvascular hematocrit in the metabolic syndrome. Microcirculation 216, 77-87.
11. 2, pH, 2, 3-DPG and temperature levels. Ann Biomed Eng 32, 1676-1693.
12. Dearborn JL, Knopman D, Sharrett AR, Schneider AL, Jack CR Jr, Coker LH, Alonso A, Selvin E, Mosley TH, Wagenknecht LE, Windham BG & Gottesman RF (2014). The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities Study (ARIC). Dement Geriatr Cogn Disord 38, 337-346.
13. Desjardins C & Duling BR (1987). Microvessel hematocrit: measurement and implications for capillary oxygen transport. Am J Physiol Heart Circ Physiol 252, H494-H503.
14. Fellmann L, Nascimento AR, Tibiriça E & Bousquet P (2013). Murine models for pharmacological studies of the metabolic syndrome. Pharmacol Ther 137, 331-340.
15. Ford ES, Li C, Zhao G, Pearson WS & Mokdad AH (2008). Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care 31, 587-589.
16. Frisbee JC (2003a). Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285, R1124-R1134.
17. Frisbee JC (2003b). Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol 285, H104-H111.
18. Frisbee JC (2004). Enhanced arteriolar α-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol 97, 764-772.
19. Frisbee JC (2005). Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 289, R307-R316.
20. Frisbee JC, Goodwill AG, Butcher JT & Olfert IM (2011). Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome. Exp Physiol 96, 369-383.
21. Frisbee JC, Hollander JM, Brock RW, Yu HG & Boegehold MA (2009). Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 296, R1771-R1782.
22. Frisbee JC & Stepp DW (2001). Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 281, H1304-H1311.
23. Frisbee JC, Wu F, Goodwill AG, Butcher JT & Beard DA (2011). Spatial heterogeneity in skeletal muscle microvascular blood flow distribution is increased in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 301, R975-R986.
24. Goodwill AG, Frisbee SJ, Stapleton PA, James ME, Frisbee JC (2009). Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome. Microcirculation 16, 667-684.
25. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; National Heart, Lung, and Blood Institute; American Heart Association (2004). Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24, e13-18.
26. Henriksen EJ, Diamond-Stanic MK & Marchionne EM (2011). Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 51, 993-999.
27. Hodnett BL, Dearman JA, Carter CB & Hester RL (2009). Attenuated PGI2 synthesis in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 296, R715-R721.
28. Jia G, Aroor AR & Sowers JR (2014). Arterial stiffness: a nexus between cardiac and renal disease. Cardiorenal Med 4, 60-71.
29. Jin JS & Bohlen HG (1997). Non-insulin-dependent diabetes and hyperglycemia impair rat intestinal flow-mediated regulation. Am J Physiol Heart Circ Physiol 272, H728-H734.
30. Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK & Peyton KJ (2006). Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 290, R601-R608.
31. Lambert EA & Lambert GW (2011). Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome. Curr Hypertens Rep 13, 244-248.
32. + channels in coronary arterial smooth muscle cells in Zucker Diabetic Fatty rats. Diabetes 54, 2155-2163.
33. Muniyappa R & Sowers JR (2013). Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 14, 5-12.
34. Musa MG, Torrens C & Clough GF (2014). The microvasculature: a target for nutritional programming and later risk of cardio-metabolic disease. Acta Physiol (Oxf) 210, 31-45.
35. Naka Y, Bucciarelli LG, Wendt T, Lee LK, Rong LL, Ramasamy R, Yan SF & Schmidt AM (2004). RAGE axis: Animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol 24, 1342-1349.
36. Overholser KA, Lomangino NA, Harris TR, Bradley JD, Bosan S (1994). Deduction of pulmonary microvascular hematocrit from indicator dilution curves. Bull Math Biol 56, 225-247.
37. Shang J, Chen Z, Wang M, Li Q, Feng W, Wu Y, Wu W, Graziano MP & Chintala M (2014). Zucker Diabetic Fatty rats exhibit hypercoagulability and accelerated thrombus formation in the arterio-venous shunt model of thrombosis. Thromb Res 134, 433-439.
38. Smith MM & Minson CT (2012). Obesity and adipokines: effects on sympathetic overactivity. J Physiol 590, 1787-1801.
39. Stainsby WN, Snyder B & Welch HG (1988). A pictographic essay on blood and tissue oxygen transport. Med Sci Sports Exerc 20, 213-221.
40. Stepp DW & Frisbee JC (2002). Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 282, H816-H820.
41. Stepp DW, Pollock DM & Frisbee JC (2004). Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 286, H964-H970.
42. Tamariz L, Palacio A, Yang Y, Parris D, Ben-Joseph R & Florez H (2010). Health economics perspective of the components of the cardiometabolic syndrome. J Clin Hypertens (Greenwich) 12, 549-555.
43. Wagner WW Jr, Todoran TM, Tanabe N, Wagner TM, Tanner JA, Glenny RW & Presson RG Jr (1999). Pulmonary capillary perfusion: intra-alveolar fractal patterns and interalveolar independence. J Appl Physiol 86, 825-831.
44. Wu F, Beard DA & Frisbee JC (2011). Computational analyses of intravascular tracer washout reveal altered capillary-level flow distributions in obese Zucker rats. J Physiol 589, 4527-4543.
45. Xiang L, Dearman J, Abram SR, Carter C & Hester RL (2008). Insulin resistance and impaired functional vasodilation in obese Zucker rats. Am J Physiol Heart Circ Physiol 294, H1658-H1666.
46. Xiang L, Naik JS, Abram SR & Hester RL (2007). Chronic hyperglycemia impairs functional vasodilation via increasing thromboxane-receptor-mediated vasoconstriction. Am J Physiol Heart Circ Physiol 292, H231-H236.
47. Xiang L, Naik JS, Hodnett BL & Hester RL (2006). Altered arachidonic acid metabolism impairs functional vasodilation in metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 290, R134-R138.
48. Zhao X, Dey A, Romanko OP, Stepp DW, Wang MH, Zhou Y, Jin L, Pollock JS, Webb RC & Imig JD (2005). Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288, R188-R196.
49. Zhou W, Wang XL, Kaduce TL, Spector AA & Lee HC (2005). Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288, H2210-H2218.